Literature DB >> 10865836

Roles of the AGE-RAGE system in vascular injury in diabetes.

Y Yamamoto1, S Yamagishi, H Yonekura, T Doi, H Tsuji, I Kato, S Takasawa, H Okamoto, J Abedin, N Tanaka, S Sakurai, H Migita, H Unoki, H Wang, T Zenda, P S Wu, Y Segawa, T Higashide, K Kawasaki, H Yamamoto.   

Abstract

This study concerns whether advanced glycation endproducts (AGE) are related to microvascular derangement in diabetes, exemplified by pericyte loss and angiogenesis in retinopathy and by mesangial expansion in nephropathy. AGE caused a decrease in viable pericytes cultivated from bovine retina. On the other hand, AGE stimulated the growth and tube formation of human microvascular endothelial cells (EC), this being mediated by autocrine vascular endothelial growth factor. In AGE-exposed rat mesangial cells, type IV collagen synthesis was induced. Those AGE actions were dependent on a cell surface receptor for AGE (RAGE), because they were abolished by RAGE antisense or ribozyme. The AGE-RAGE system may thus participate in the development of diabetic microangiopathy. This proposition was supported by experiments with animal models; several indices characteristic of retinopathy were correlated with circulating AGE levels in OLETF rats. The predisposition to nephropathy was augmented in RAGE transgenic mice when they became diabetic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865836     DOI: 10.1111/j.1749-6632.2000.tb06311.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.

Authors:  Hideto Yonekura; Yasuhiko Yamamoto; Shigeru Sakurai; Ralica G Petrova; Md Joynal Abedin; Hui Li; Kiyoshi Yasui; Masayoshi Takeuchi; Zenji Makita; Shin Takasawa; Hiroshi Okamoto; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

2.  Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH.

Authors:  Yuki Kimura; Hideyuki Hyogo; Sho-ichi Yamagishi; Masayoshi Takeuchi; Tomokazu Ishitobi; Yoshitaka Nabeshima; Koji Arihiro; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2010-01-30       Impact factor: 7.527

3.  Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.

Authors:  K C B Tan; S W M Shiu; W S Chow; L Leng; R Bucala; D J Betteridge
Journal:  Diabetologia       Date:  2006-09-13       Impact factor: 10.122

4.  The expression of receptor for advanced glycation end products is associated with angiogenesis in human oral squamous cell carcinoma.

Authors:  Tomonori Sasahira; Tadaaki Kirita; Ujjal K Bhawal; Masayuki Ikeda; Akira Nagasawa; Kazuhiko Yamamoto; Hiroki Kuniyasu
Journal:  Virchows Arch       Date:  2007-01-19       Impact factor: 4.064

5.  Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells.

Authors:  Keiko Iwamoto; Keishi Kanno; Hideyuki Hyogo; Sho-Ichi Yamagishi; Masayoshi Takeuchi; Susumu Tazuma; Kazuaki Chayama
Journal:  J Gastroenterol       Date:  2008-05-06       Impact factor: 7.527

6.  Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes.

Authors:  K C B Tan; W S Chow; A W K Tso; A Xu; H F Tse; R L C Hoo; D J Betteridge; K S L Lam
Journal:  Diabetologia       Date:  2007-07-18       Impact factor: 10.122

7.  Dietary flaxseed oil and fish oil ameliorates renal oxidative stress, protein glycation, and inflammation in streptozotocin-nicotinamide-induced diabetic rats.

Authors:  Nivedita M Jangale; Prasad P Devarshi; Sneha B Bansode; Mahesh J Kulkarni; Abhay M Harsulkar
Journal:  J Physiol Biochem       Date:  2016-04-05       Impact factor: 4.158

Review 8.  Regulation of RAGE for attenuating progression of diabetic vascular complications.

Authors:  Myat Thu Thu Win; Yasuhiko Yamamoto; Seiichi Munesue; Hidehito Saito; Dong Han; So Motoyoshi; Tarek Kamal; Takuro Ohara; Takuo Watanabe; Hiroshi Yamamoto
Journal:  Exp Diabetes Res       Date:  2011-10-29

Review 9.  Redox implications in adipose tissue (dys)function--A new look at old acquaintances.

Authors:  Aleksandra Jankovic; Aleksandra Korac; Biljana Buzadzic; Vesna Otasevic; Ana Stancic; Andreas Daiber; Bato Korac
Journal:  Redox Biol       Date:  2015-07-02       Impact factor: 11.799

10.  Network Pharmacology and Molecular Docking Study on the Potential Mechanism of Yi-Qi-Huo-Xue-Tong-Luo Formula in Treating Diabetic Peripheral Neuropathy.

Authors:  Yixuan Lin; Chuqiao Shen; Fanjing Wang; Zhaohui Fang; Guoming Shen
Journal:  J Diabetes Res       Date:  2021-05-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.